🇸🇪 Sweden Country × Condition
breast cancer Clinical Trials in Sweden
Active clinical trials for breast cancer with research sites in Sweden. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇸🇪 Sweden
Active Trials in Sweden (4)
NCT05722795
Recruiting
Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
Enrollment
40 pts
Country
🇸🇪 Sweden
Vastra Gotaland Region
View Trial → NCT06719206
Recruiting
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Enrollment
172 pts
Country
🇸🇪 Sweden
Mälardalen University
View Trial → NCT06401304
Recruiting
Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
Enrollment
1,200 pts
Country
🇸🇪 Sweden
Uppsala University
View Trial → NCT05900206 Phase 2
Recruiting
Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer
Enrollment
370 pts
Country
🇸🇪 Sweden
Karolinska University Hospital
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in Sweden?
There are currently 4 active clinical trials for breast cancer with sites in Sweden, of which 4 are actively recruiting patients.
How can I join a breast cancer clinical trial in Sweden?
To join a breast cancer clinical trial in Sweden, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Sweden directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in Sweden?
Active breast cancer trials in Sweden span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology